Files
2026-07-06 17:28:36 -04:00

6.8 KiB
Raw Permalink Blame History

type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
type title description jurisdiction legislature session identifier citation classification subjects status primary_sponsors version_count action_count vote_count first_action last_action source source_identifier source_url source_hash vintage source_snapshot retrieved_at confidence tags
Bill Accrual of cause of action; diagnosis of latent injury. Accrual of cause of action; diagnosis of latent injury or disease. Provides that a cause of action for a latent injury shall accrue when such injury and its causal connection to an injurious or disease-causing substance, product, or circumstance is first communicated to the injured person or his agent by a physician. The bill further provides that a diagnosis of a nonmalignant substance-related, product-related, or circumstance-related latent injury or disease shall not accrue an action based upon the subsequent diagnosis of a malignant substance-related latent injury or disease. us/states/va Virginia General Assembly 2021 HB 2139 Virginia HB 2139 (2021)
bill
enacted
Elizabeth R. Guzman
5 39 9 2021-01-12 2021-03-18 openstates ocd-bill/7c6661db-12c9-4223-b66c-fce3306ed71c https://lis.virginia.gov/cgi-bin/legp604.exe?212+sum+HB2139 57871f1e0eb2e2af1c00d98dcb050a4cd2c688eb650e0714f7b8bb7415003780 2026-07-01 https://data.openstates.org/daily/2026-07-01/public.pgdump 2026-07-06 reported
legislation
bill
us-va

Virginia HB 2139 (2021) — Accrual of cause of action; diagnosis of latent injury.

Accrual of cause of action; diagnosis of latent injury or disease. Provides that a cause of action for a latent injury shall accrue when such injury and its causal connection to an injurious or disease-causing substance, product, or circumstance is first communicated to the injured person or his agent by a physician. The bill further provides that a diagnosis of a nonmalignant substance-related, product-related, or circumstance-related latent injury or disease shall not accrue an action based upon the subsequent diagnosis of a malignant substance-related latent injury or disease.

Version chain

The bill's text revisions, in order — the diff chain from filing to enrollment.

  1. CHAP0195 (committee substitute) — source
  2. Committee substitute printed 21200305D-S1 (committee substitute) — source
  3. HB2139ER (committee substitute) — source
  4. Prefiled and ordered printed; offered 01/13/21 21102437D (committee substitute) — source
  5. Printed as engrossed 21102437D-E (committee substitute) — source

Votes

  • Continued to 2021 Sp. Sess. 1 in Judiciary (14-Y 0-N) — 140 (pass) · upper
  • Reported from Judiciary with substitute (10-Y 4-N) — 104 (pass) · upper
  • Subcommittee recommends reporting with amendments (7-Y 1-N) — 71 (pass) · lower
  • VOTE: Adoption (95-Y 0-N) — 940 (pass) · lower
  • Passed by indefinitely in Judiciary with letter (13-Y 2-N) — 132 (pass) · upper
  • Reported from Courts of Justice with amendment(s) (22-Y 0-N) — 220 (pass) · lower
  • Constitutional reading dispensed (32-Y 0-N) — 320 (pass) · upper
  • Passed Senate with substitute (30-Y 8-N) — 308 (pass) · upper
  • VOTE: Block Vote Passage (100-Y 0-N) — 990 (pass) · lower

Sponsors

  • Elizabeth R. Guzman — primary (person)
  • Ibraheem S. Samirah — cosponsor (person)
  • Kaye Kory — cosponsor (person)
  • Kenneth R. Plum — cosponsor (person)
  • Lee J. Carter — cosponsor (person)
  • Marcus B. Simon — cosponsor (person)
  • Mark H. Levine — cosponsor (person)
  • Mark L. Keam — cosponsor (person)
  • Michael P. Mullin — cosponsor (person)
  • Patrick A. Hope — cosponsor (person)

Timeline

The legislative action history — every referral, reading, and vote.

  • 2021-01-12 Prefiled and ordered printed; offered 01/13/21 21102437D introduction
  • 2021-01-12 Referred to Committee for Courts of Justice referral-committee
  • 2021-01-21 Assigned Courts sub: Civil referral-committee
  • 2021-01-22 House subcommittee amendments and substitutes offered
  • 2021-01-22 Subcommittee recommends reporting with amendments (7-Y 1-N)
  • 2021-01-27 House committee, floor amendments and substitutes offered
  • 2021-01-27 House committee, floor amendments and substitutes offered
  • 2021-01-27 Reported from Courts of Justice with amendment(s) (22-Y 0-N) committee-passage
  • 2021-01-28 Read first time reading-1
  • 2021-01-29 Read second time reading-2
  • 2021-01-29 Committee amendments agreed to
  • 2021-01-29 Engrossed by House as amended HB2139E
  • 2021-01-29 Printed as engrossed 21102437D-E
  • 2021-02-01 Read third time and passed House BLOCK VOTE (100-Y 0-N) passage, reading-3
  • 2021-02-01 VOTE: Block Vote Passage (100-Y 0-N)
  • 2021-02-02 Constitutional reading dispensed
  • 2021-02-02 Referred to Committee on the Judiciary referral-committee
  • 2021-02-05 Continued to 2021 Sp. Sess. 1 in Judiciary (14-Y 0-N)
  • 2021-02-10 Passed by indefinitely in Judiciary with letter (13-Y 2-N)
  • 2021-02-15 Reconsidered by Judiciary
  • 2021-02-15 Senate committee, floor amendments and substitutes offered
  • 2021-02-17 Senate committee, floor amendments and substitutes offered
  • 2021-02-17 Committee substitute printed 21200305D-S1 substitution
  • 2021-02-17 Reported from Judiciary with substitute (10-Y 4-N) committee-passage
  • 2021-02-19 Constitutional reading dispensed (32-Y 0-N)
  • 2021-02-22 Read third time reading-3
  • 2021-02-22 Reading of substitute waived
  • 2021-02-22 Committee substitute agreed to 21200305D-S1
  • 2021-02-22 Engrossed by Senate - committee substitute HB2139S1
  • 2021-02-22 Passed Senate with substitute (30-Y 8-N) passage
  • 2021-02-23 Placed on Calendar
  • 2021-02-23 Senate substitute agreed to by House 21200305D-S1 (95-Y 0-N)
  • 2021-02-23 VOTE: Adoption (95-Y 0-N)
  • 2021-02-25 Enrolled
  • 2021-02-25 Signed by President
  • 2021-02-26 Signed by Speaker
  • 2021-03-01 Enrolled Bill communicated to Governor on March 1, 2021
  • 2021-03-01 Governor's Action Deadline 11:59 p.m., March 31, 2021
  • 2021-03-18 Approved by Governor-Chapter 195 (effective 7/1/21) executive-signature

Source

OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/7c6661db-12c9-4223-b66c-fce3306ed71c. Confidence: reported (aggregated from official Virginia legislature records).